OraSure Technologies (OSUR) Stock Price, News & Analysis

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OSUR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSUR, but not buy additional shares or sell existing shares.
View OSUR analyst ratings or view top-rated stocks.

3 brokers have issued 12 month price targets for OraSure Technologies' stock. Their OSUR share price targets range from $5.00 to $9.00. On average, they expect the company's stock price to reach $6.38 in the next year. This suggests a possible upside of 20.7% from the stock's current price.
View analysts price targets for OSUR or view top-rated stocks among Wall Street analysts.

OraSure Technologies' stock was trading at $8.20 at the beginning of 2024. Since then, OSUR stock has decreased by 35.6% and is now trading at $5.28.
View the best growth stocks for 2024 here.

OraSure Technologies saw a decrease in short interest in March. As of March 31st, there was short interest totaling 2,960,000 shares, a decrease of 29.2% from the March 15th total of 4,180,000 shares. Based on an average daily volume of 936,100 shares, the short-interest ratio is presently 3.2 days. Currently, 4.2% of the company's shares are sold short.
View OraSure Technologies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our OSUR earnings forecast.

OraSure Technologies, Inc. (NASDAQ:OSUR) issued its earnings results on Tuesday, February, 27th. The medical instruments supplier reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.09. The medical instruments supplier earned $75.88 million during the quarter, compared to analysts' expectations of $74.13 million. OraSure Technologies had a net margin of 13.23% and a trailing twelve-month return on equity of 14.50%. The firm's quarterly revenue was down 38.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.21 earnings per share.

ETFs with the largest weight of OraSure Technologies (NASDAQ:OSUR) stock in their portfolio include Invesco S&P SmallCap 600 Pure Growth ETF (RZG) and Amplify Treatments, Testing and Advancements ETF (GERM).Hartford Multifactor Small Cap ETF (ROSC).

OraSure Technologies issued an update on its first quarter 2024 earnings guidance on Wednesday, April, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $50.0 million-$54.0 million, compared to the consensus revenue estimate of $52.1 million.

2 employees have rated OraSure Technologies Chief Executive Officer Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among the company's employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

OraSure Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (0.64%), Los Angeles Capital Management LLC (0.45%) and Counterpoint Mutual Funds LLC (0.03%). Insiders that own company stock include Kathleen Gallagher Weber, Michael Celano, Nancy J Gagliano and Ronny B Lancaster.
View institutional ownership trends.

Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.